Precision medicine is often touted as the future of medicine. But so far, it hasn’t been helpful in the war against COVID-19. Here is how it could be used to tease apart the nuances of the disease.
David Welch, University of Auckland, Waipapa Taumata Rau
Genetic analysis of virus samples from New Zealand’s latest COVID-19 cases is now much swifter. It’s providing key information, but hasn’t yet answered the question of where this second wave started.
Are there innate differences between female and male brains?
SebastianKaulitzki/Science Photo Library via Getty Images
New research provides a template for understanding the role of genetic switches in the development of complex diseases whose causes have so far evaded scrutiny.
A man with ALS uses a head-mounted laser pointer to communicate with his wife, by pointing to letters and words on a communication board.
Fezcat via Wikipedia.com
Amyotrophic lateral sclerosis, Lou Gehrig’s disease, is a crippling, progressive neurodegenerative disease for which there is no cure. Now it seems that a diabetes drug may help some cases.
Our method could someday potentially detect the disease before it starts developing in a person’s brain.
Robert Kneschke/ Shutterstock
Researchers from Oregon Health and Science University found that variations in genes that code for parts of the cellular alarm system might play a role in how well people fight off COVID-19.
A man being tested as he takes part in an ophthalmological study and examination.
Tony Karumba/AFP via Getty Images
Knowing genetic associations in specific populations will make it possible to focus prevention and treatment on those who will benefit most, sparing expense and side effects from those who will not.
Under pressure to develop a coronavirus vaccine, researchers have turned to protein synthesis, genetics and hybrid viruses. It is likely a mix of these approaches will be used to fight the coronavirus.
World Down Syndrome Day recognizes people living with Down syndrome and those who support them.
(Shutterstock)
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford